Abstract:Adipose tissues are the major organ that controls systemic energy metabolism and maintain homeostasis. There are two major classes of adipocytes. White adipocytes store and release lipids, while brown adipocytes generate heat by uncoupling oxidative phosphorylation through the action of mitochondrial uncoupling protein 1. In addition, cold exposure and β3 stimulation induce development of brown cell-like "beige" adipocytes in white adipose tissues. Brown adipose tissue and/or beige fat-mediated thermogenesis suppresses high-fat-diet-associated obesity in mice. Therefore, there is great expectation that brown/beige fat activity can be increased to reduce obesity and metabolic disease. Fibroblast growth factor 21 (FGF21) is an important metabolic regulator of glucose and lipid homeostasis, and is expressed in multiple tissues including liver, pancreas, white and brown adipose tissues, and skeletal muscle. In addition, FGF21 is being pursued as a therapeutic target for diabetes and obesity because of its benefits in regulating glucose and lipid metabolism. In this study, a total of 88 crude herbal drugs frequently used in Kampo prescriptions (traditional Japanese medicine) were selected and screened for up-regulation of expression of FGF21 in beige adipocytes. As a result, we found that berberine, an isoquinoline alkaloid, significantly increased FGF21 expression in brown and beige adipocytes. Furthermore, we investigated the target molecule of berberine in regulation of the FGF21 expression in beige adipocytes. To address this, total RNA was extracted from in beige adipocytes after exposure to berberine, and analyzed by real time qRT-PCR. We found the expression of FGF21 mRNA was significantly increased by berberine in beige adipocytes. Additionally, the up-regulation of FGF21 mRNA by berberine was completely abolished by an AMP-activated kinase (AMPK) inhibitor, compound C, in beige adipocytes. These findings suggested that berberine stimulated FGF21 expression through activation of AMPK signaling pathway in brown and beige adipocytes.

Berberine Hydrochloride Induces Brown Adipogenesis

Berberine Activates Thermogenesis in White and Brown Adipose Tissue.

Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans

Berberine Ameliorates Obesity by Inducing GDF15 Secretion by Brown Adipocytes

Berberine is a Potential Therapeutic Agent for Metabolic Syndrome Via Brown Adipose Tissue Activation and Metabolism Regulation.

Berberine remodels adipose tissue to attenuate metabolic disorders by activating sirtuin 3

Berberine Hydrochloride Protects Cytokine-Induced Inflammation through Multiple Pathways

Berberine Protected Rats Against Adiposity Induced By High-Fat Diets

Brown Adipogenic Reprogramming Induced by a Small Molecule

Tetrahydroberberrubine exhibits preventive effect on obesity by activating PGC1α-mediated thermogenesis in white and brown adipose tissue

Berberine enhances Ucp1 expression via modulating the NFE2 response element in cold environments: New perspectives on the thermogenesis in brown adipose tissue

Berberine attenuates obesity‐induced insulin resistance by inhibiting miR‐27a secretion

Berberine stimulates FGF21 expression via activation of AMP-activated protein kinase in brown and beige adipocytes

Berberine modulates deacetylation of PPARγ to promote adipose tissue remodeling and thermogenesis via AMPK/SIRT1 pathway

[Effect of berberine on the differentiation of adipocyte].

Reduced UCP-1 Content in In Vitro Differentiated Beige/Brite Adipocytes Derived from Preadipocytes of Human Subcutaneous White Adipose Tissues in Obesity

Theobromine enhances the conversion of white adipocytes into beige adipocytes in a PPARγ activation-dependent manner

The Role of Berberine in the Prevention of HIF-1α Activation to Alleviate Adipose Tissue Fibrosis in High-Fat-Diet-Induced Obese Mice

A Method to Induce Brown/Beige Adipocyte Differentiation from Murine Preadipocytes

Berberine Ameliorates High-fat-induced Insulin Resistance in HepG2 Cells by Modulating PPARs Signaling Pathway

Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation